Life ScienceCompany
Parexel has acquired 16 companies of its own. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.
Parexel’s largest acquisition to date was in 2012, when it acquired Liquent for $72M. Parexel has acquired in 5 different US states, and 5 countries. The Company’s most targeted sectors include life science (57%) and business services (13%).
Join Mergr and gain access to Parexel’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity17
- M&A Buy Activity16
- M&A Sell Activity1
- Total Sectors Invested 6
- Total Countries Invested 5
- M&A Buy/Sell Connections 3
- M&A Advisors 1
Unlimited Searches
